Journal
JOURNAL OF CONTROLLED RELEASE
Volume 324, Issue -, Pages 633-643Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2020.05.030
Keywords
Drug delivery; Transcellular transport; Cell-penetrating peptides; Polyarginine; Microvessel; Peptide proteolysis
Funding
- National Institutes of Health [NINDS 1F31NS101875, NCI 5T32CA153952-08, NIGMS 1R01GM111824, N5106008, NIGM068619, NINDS R01NS106008]
- National Science Foundation [DMR1709892]
- Defense Threat Reduction Agency [HDTRA1-15-1-0046]
Ask authors/readers for more resources
The rate of transport of small molecule drugs across biological barriers, such as the blood-brain barrier, is often a limiting factor in achieving a therapeutic dose. One proposed strategy to enhance delivery across endothelial or epithelial monolayers is conjugation to cell-penetrating peptides (CPPs); however, very little is known about the design of CPPs for efficient transcellular transport. Here, we report on transcellular transport of a CPP, designated the CL peptide, that increases the delivery of small-molecule cargoes across model epithelium approximately 10-fold. The CL peptide contains a helix-like motif and a polyarginine tail. We investigated the effect of cargo, helix-like motif sequence, polyarginine tail length, and peptide stereochemistry on cargo delivery. We showed that there is an optimal helix-like motif sequence (RLLRLLR) and polyarginine tail length (R7) for cargo delivery. Furthermore, we demonstrated that the peptide-cargo conjugate is cleaved by cells in the epithelium at the site of a two-amino acid linker. The cleavage releases the cargo with the N-terminal linker amino acid from the peptide prior to transport out of the epithelium. These studies provide new insight into the sequence requirements for developing novel CPPs for transcellular delivery of cargo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available